The world's first saliva-based pregnancy test is set to arrive in shops across Europe, South Africa, the United Arab Emirates and Israel at the beginning of 2023.
The SaliStick test kit, developed by Israeli start-up Salignostics, delivers results in ten minutes.
Developers said the test - whose price is described as "competitive" but has not been confirmed yet - detects pregnancy on the first day of a missed period.
It does not require a blood or urine sample, but just a sample of a patient's saliva.
SaliStick its have acquired European CE certification and the firm claims to be in advanced discussions with distributors to begin delivering the products in the first quarter of 2023.
Professor Aaron Palmon, the co-founder of Salignostics, said: "Saliva is the key to rapid diagnostics for a variety of medical reasons.
"It is the only non-invasive, easy, and hygienic means to detect hormones, viruses, and even diseases.
"With SaliStick, we leverage the powerful diagnostics abilities we have been able to create from analyzing saliva.
"This product completely removes the need for blood and urine samples when testing for pregnancy."
According to the company's analysis, SaliStick is set to win significant market share due to its unique and innovative user experience.
SaliStick will be presented at the Medica 2022 Trade Fair in Düsseldorf, Germany, which will take place between November 14 and November 17.
Among other innovations, Salignostics developed products to detect malaria, cardiac risk, Helicobacter pylori and other diseases.
The company has raised a total of $16million (£13.60million) to date, and is now raising additional funding to support sales, marketing, and R&D.
